ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

38,709Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 457

$1.33M Total Retail Price of All Prescriptions

Rank: 23 out of 457

1,116 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 1,116 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 32,300 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
LOVASTATIN 2,098 1,758 10 1 25
OMEPRAZOLE 1,953 1,580 2 1
LISINOPRIL 1,765 1,441 3 3
AMLODIPINE BESYLATE 1,764 1,564 4 4
METFORMIN HCL 1,687 1,405 10 5 6
HYDROCHLOROTHIAZIDE 1,330 1,122 6 8
CARVEDILOL 1,316 1,164 7 20
LEVOTHYROXINE SODIUM 1,182 1,047 8 5
CITALOPRAM HBR 928 771 9 45
FUROSEMIDE 763 676 10 10
BENAZEPRIL HCL 752 653 11 114
MELOXICAM 700 553 12 41
GLIPIZIDE 665 562 13 42
METOPROLOL TARTRATE 542 459 14 7
ZOLPIDEM TARTRATE 540 431 15 13
RANITIDINE HCL 511 451 16 17
POTASSIUM CHLORIDE 478 416 17 28
IBUPROFEN 450 325 18 14
HYDROCODONE-ACETAMINOPHEN 414 292 S3 19 23
SERTRALINE HCL 414 334 19 57
GABAPENTIN 402 279 21 15
ALENDRONATE SODIUM 397 386 22 16
SIMVASTATIN 384 310 23 2
ISOSORBIDE MONONITRATE ER 382 330 24 84
LISINOPRIL-HYDROCHLOROTHIAZIDE 374 325 25 37
ENALAPRIL MALEATE 373 353 26 35
ATENOLOL 331 290 27 11
PRAVASTATIN SODIUM 327 303 28 29
TAMSULOSIN HCL 321 282 29 36
BENAZEPRIL-HYDROCHLOROTHIAZIDE 318 278 30 221
CRESTOR 317 259 31 9
MECLIZINE HCL 307 260 32 55
ALPRAZOLAM 304 271 33 39
AZITHROMYCIN 286 228 34 44
LOSARTAN POTASSIUM 277 268 35 18
CIPROFLOXACIN HCL 247 216 36 71
WARFARIN SODIUM 243 226 37 38
CLOPIDOGREL 239 190 38 19
PREDNISONE 235 177 39 95
TEMAZEPAM 232 185 40 48
NAPROXEN 223 175 41 65
PLAVIX 223 182 41 24
NEXIUM 218 162 43 12
LOSARTAN-HYDROCHLOROTHIAZIDE 201 182 44 54
ADVAIR DISKUS 193 173 45 27
TRAMADOL HCL 182 135 46 26
CLOTRIMAZOLE-BETAMETHASONE 177 134 47 60
LORAZEPAM 172 151 48 87
POLYETHYLENE GLYCOL 3350 171 154 49 187
ATORVASTATIN CALCIUM 161 146 50 33
FENOFIBRATE 160 98 51 46
FLUOXETINE HCL 159 125 52 108
DOXAZOSIN MESYLATE 158 151 53 73
ALLOPURINOL 158 145 53 47
NAMENDA 156 156 55 32
DIOVAN HCT 149 140 56 51
CLONIDINE HCL 148 137 57 52
BUMETANIDE 148 137 57 123
CELEBREX 141 129 59 53
INSULIN SYRINGE 138 106 60 79
VENTOLIN HFA 137 98 61 96
DICLOFENAC SODIUM 135 90 62 49
SINGULAIR 130 112 63 43
LYRICA 128 89 64 77
PROAIR HFA 121 92 65 66
MUPIROCIN 121 101 65 91
PAROXETINE HCL 114 97 67 68
PENTOXIFYLLINE 114 108 67 67
DONEPEZIL HCL 113 113 69 22
DIOVAN 111 105 70 30
LANTUS 111 77 70 56
SPIRONOLACTONE 110 83 72 124
SULFAMETHOXAZOLE-TRIMETHOPRIM 102 87 73 153
DIGOXIN 101 101 74 69
VERAPAMIL ER 101 101 74 145
PANTOPRAZOLE SODIUM 101 75 74 59
FAMOTIDINE 99 86 77 62
AMITRIPTYLINE HCL 98 80 R 78 156
ESCITALOPRAM OXALATE 97 75 79 61
GLYBURIDE 97 86 R 79 64
MONTELUKAST SODIUM 90 77 81 86
ACTOS 90 78 81 105
FOLIC ACID 89 77 83 81
AVODART 89 89 83 110
FLUTICASONE PROPIONATE 88 73 85 40
TRIAMCINOLONE ACETONIDE 88 71 85 132
BENICAR HCT 85 85 87 111
BENICAR 84 84 88 90
FINASTERIDE 80 76 89 85
OXYBUTYNIN CHLORIDE 80 58 89 142
AMOXICILLIN 79 63 91 174
NIFEDIPINE ER 79 63 91 89
CILOSTAZOL 77 62 93 88
LOVAZA 77 58 93 50
TRAZODONE HCL 74 46 95 104
SYMBICORT 72 57 96 106
NITROSTAT 68 46 97 167
AMOX TR-POTASSIUM CLAVULANATE 66 55 98 202
QUETIAPINE FUMARATE 65 31 99 109
EXELON 65 65 99 98
DICLOFENAC POTASSIUM 64 41 101 164
KLOR-CON M20 64 52 101 227
NOVOLOG MIX 70-30 62 49 103 190
COMBIVENT 60 59 104 133
KLOR-CON 10 58 53 105 161
LEXAPRO 57 39 106 138
GLYBURIDE-METFORMIN HCL 56 54 R 107 70
NYSTATIN 56 29 107 234
LANTUS SOLOSTAR 55 31 109 121
DILTIAZEM ER 55 31 109 217
GLIMEPIRIDE 54 34 111 75
LIPITOR 54 48 111 205
BYSTOLIC 54 50 111 122
GEMFIBROZIL 53 40 114 112
JANUVIA 53 39 114 80
PROVENTIL HFA 52 50 116 454
AMLODIPINE BESYLATE-BENAZEPRIL 51 36 117 72
SOTALOL 50 33 118 459
DIAZEPAM 50 41 118 308
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.